Breaking News Instant updates and real-time market news.

VXRT

Vaxart

$7.41 /

+0.505 (+7.32%)

12:45
03/16/21
03/16
12:45
03/16/21
12:45

Vaxart call volume above normal and directionally bullish

Bullish option flow detected in Vaxart with 16,603 calls trading, 2x expected, and implied vol increasing almost 2 points to 153.83%. Mar-21 8 calls and Mar-21 7.5 calls are the most active options, with total volume in those strikes near 5,100 contracts. The Put/Call Ratio is 0.09. Earnings are expected on May 13th.

VXRT Vaxart
$7.41 /

+0.505 (+7.32%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR

TODAY'S FREE FLY STORIES

Downgrade
Dufry downgraded to Reduce from Add at Baader Helvea » 05:22
12/03/21
12/03
05:22
12/03/21
05:22
DUFRY

Dufry

$4.47 /

+0.045 (+1.02%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DUFRY Dufry
$4.47 /

+0.045 (+1.02%)

11/03/21 Morgan Stanley
Dufry price target raised to CHF 58 from CHF 55 at Morgan Stanley
10/20/21 Deutsche Bank
Dufry initiated with a Hold at Deutsche Bank
08/16/21 RBC Capital
Dufry upgraded to Sector Perform from Underperform at RBC Capital
06/15/21 Oddo BHF
Dufry upgraded to Outperform from Neutral at Oddo BHF
Downgrade
Novartis downgraded to Neutral from Buy at Bryan Garnier » 05:20
12/03/21
12/03
05:20
12/03/21
05:20
NVS

Novartis

$79.96 /

+0.11 (+0.14%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

11/05/21 UBS
Novartis downgraded to Neutral on lower near-term growth at UBS
11/05/21 UBS
Novartis downgraded to Neutral from Buy at UBS
10/27/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 84 at JPMorgan
10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

Upgrade
Stitch Fix upgraded to Equal Weight from Underweight at Morgan Stanley » 05:19
12/03/21
12/03
05:19
12/03/21
05:19
SFIX

Stitch Fix

$22.95 /

+0.4 (+1.77%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

12/02/21 MKM Partners
Stitch Fix price target lowered to $19 from $31 at MKM Partners
12/02/21 UBS
Stitch Fix initiated with a Neutral at UBS
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
10/04/21 Wedbush
Stitch Fix initiated with a Neutral at Wedbush
SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

SFIX Stitch Fix
$22.95 /

+0.4 (+1.77%)

Upgrade
Morgan Stanley upgraded to Buy from Neutral at Citi » 05:17
12/03/21
12/03
05:17
12/03/21
05:17
MS

Morgan Stanley

$98.87 /

+3.515 (+3.69%)

Citi analyst Keith…

Citi analyst Keith Horowitz upgraded Morgan Stanley to Buy from Neutral with a price target of $115, up from $105. The analyst is "very constructive" on bank stocks and would use the recent pullback in the shares to build positions "in high quality names." After meeting with management, the analyst sees further multiple expansion for Morgan Stanley as the company delivers on its wealth management opportunity "and is awarded a growth multiple." Horowitz says the stock offers "high quality at a reasonable price."

ShowHide Related Items >><<
MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

10/18/21 Citi
Morgan Stanley price target raised to $105 from $100 at Citi
10/15/21
Fly Intel: Top five analyst downgrades
10/15/21 BMO Capital
Morgan Stanley price target raised to $109 from $107 at BMO Capital
10/15/21 Piper Sandler
Morgan Stanley price target raised to $110 from $103 at Piper Sandler
MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

MS Morgan Stanley
$98.87 /

+3.515 (+3.69%)

General news
FX Action: » 05:15
12/03/21
12/03
05:15
12/03/21
05:15
$ECON

Economic Data

/

+

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Barratt Developments initiated with a Buy at Investec » 05:14
12/03/21
12/03
05:14
12/03/21
05:14
BTDPY

Barratt Developments

$19.01 /

+0.62 (+3.37%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTDPY Barratt Developments
$19.01 /

+0.62 (+3.37%)

11/23/21 Berenberg
Barratt Developments upgraded to Buy from Hold at Berenberg
10/13/21 Peel Hunt
Barratt Developments upgraded to Buy from Add at Peel Hunt
07/22/21 BofA
Barratt Developments upgraded to Buy from Neutral at BofA
07/15/21 JPMorgan
Barratt Developments price target raised to 860 GBp from 850 GBp at JPMorgan
Initiation
Berkeley Group initiated with a Buy at Investec » 05:14
12/03/21
12/03
05:14
12/03/21
05:14
BKGFF

Berkeley Group

$59.01 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKGFF Berkeley Group
$59.01 /

+ (+0.00%)

12/02/21 JPMorgan
Berkeley Group price target lowered to 5,500 GBp from 5,848 GBp at JPMorgan
11/23/21 Berenberg
Berkeley Group price target lowered to 4,120 GBp from 4,640 GBp at Berenberg
09/22/21 Deutsche Bank
Berkeley Group price target raised to 4,555 GBp from 4,420 GBp at Deutsche Bank
05/10/21 JPMorgan
Berkeley Group upgraded to Overweight from Neutral at JPMorgan
Initiation
Persimmon initiated with a Buy at Investec » 05:13
12/03/21
12/03
05:13
12/03/21
05:13
PSMMY

Persimmon

$74.93 /

+1.45 (+1.97%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSMMY Persimmon
$74.93 /

+1.45 (+1.97%)

11/23/21 Berenberg
Persimmon price target raised to 3,410 GBp from 3,340 GBp at Berenberg
08/19/21 JPMorgan
Persimmon price target raised to 3,470 GBp from 3,420 GBp at JPMorgan
08/19/21 Morgan Stanley
Persimmon price target lowered to 3,250 GBp from 3,300 GBp at Morgan Stanley
07/09/21 JPMorgan
Persimmon price target raised to 3,015 GBp from 2,915 GBp at JPMorgan
Initiation
Redrow initiated with a Buy at Investec » 05:12
12/03/21
12/03
05:12
12/03/21
05:12
RDWWF

Redrow

$8.55 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDWWF Redrow
$8.55 /

+ (+0.00%)

11/23/21 Berenberg
Redrow price target raised to 980 GBp from 880 GBp at Berenberg
11/15/21 Barclays
Redrow price target raised to 840 GBp from 820 GBp at Barclays
11/15/21 Deutsche Bank
Redrow price target raised to 809 GBp from 800 GBp at Deutsche Bank
11/15/21 JPMorgan
Redrow price target raised to 870 GBp from 850 GBp at JPMorgan
Initiation
Bellway initiated with a Buy at Investec » 05:12
12/03/21
12/03
05:12
12/03/21
05:12
BLWYF

Bellway

$46.40 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLWYF Bellway
$46.40 /

+ (+0.00%)

11/23/21 Berenberg
Bellway price target raised to 4,230 GBp from 4,180 GBp at Berenberg
10/29/21 Barclays
Bellway price target raised to 3,800 GBp from 3,700 GBp at Barclays
10/27/21 Deutsche Bank
Bellway price target raised to 3,524 GBp from 3,407 GBp at Deutsche Bank
10/20/21 JPMorgan
Bellway price target raised to 4,200 GBp from 4,100 GBp at JPMorgan
Initiation
Taylor Wimpey initiated with a Buy at Investec » 05:12
12/03/21
12/03
05:12
12/03/21
05:12
TWODF

Taylor Wimpey

$2.10 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWODF Taylor Wimpey
$2.10 /

+ (+0.00%)

08/09/21 Barclays
Taylor Wimpey price target raised to 205 GBp from 195 GBp at Barclays
08/05/21 Morgan Stanley
Taylor Wimpey price target raised to 195 GBp from 190 GBp at Morgan Stanley
06/14/21 Morgan Stanley
Taylor Wimpey price target lowered to 190 GBp from 195 GBp at Morgan Stanley
06/07/21 Liberum
Taylor Wimpey upgraded to Buy from Hold at Liberum
Initiation
Vistry Group initiated with a Buy at Investec » 05:11
12/03/21
12/03
05:11
12/03/21
05:11
BVHMF

Vistry Group

$16.45 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BVHMF Vistry Group
$16.45 /

+ (+0.00%)

11/23/21 Berenberg
Vistry Group price target raised to 1,560 GBp from 1,490 GBp at Berenberg
12/15/20 JPMorgan
Vistry Group price target raised to 900 GBp from 800 GBp at JPMorgan
12/07/20 Deutsche Bank
Vistry Group downgraded to Sell from Hold at Deutsche Bank
Recommendations
Marvell price target raised to $110 from $100 at Oppenheimer » 05:11
12/03/21
12/03
05:11
12/03/21
05:11
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Oppenheimer analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
11/30/21 BMO Capital
Marvell price target raised to $85 from $70 at BMO Capital
11/29/21 B. Riley
Marvell price target raised to $90 from $83 at B. Riley
11/29/21 JPMorgan
Marvell price target raised to $85 from $74 at JPMorgan
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Upgrade
Rotork upgraded to Overweight from Neutral at JPMorgan » 05:09
12/03/21
12/03
05:09
12/03/21
05:09
RTOXF

Rotork

$4.64 /

+0.09 (+1.98%)

JPMorgan analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTOXF Rotork
$4.64 /

+0.09 (+1.98%)

11/08/21 Morgan Stanley
Rotork price target raised to EUR 410 from EUR 406 at Morgan Stanley
09/07/21 Morgan Stanley
Rotork price target raised to 406 GBp from 400 GBp at Morgan Stanley
08/09/21 UBS
Rotork price target lowered to 360 GBp from 365 GBp at UBS
08/06/21 Berenberg
Rotork price target lowered to 425 GBp from 430 GBp at Berenberg
Downgrade
Alfa Laval downgraded to Underweight from Neutral at JPMorgan » 05:07
12/03/21
12/03
05:07
12/03/21
05:07
ALFVY

Alfa Laval

$39.46 /

+0.68 (+1.75%)

JPMorgan analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$39.46 /

+0.68 (+1.75%)

10/28/21 Credit Suisse
Alfa Laval price target raised to SEK 365 from SEK 345 at Credit Suisse
10/27/21 Morgan Stanley
Alfa Laval price target raised to SEK 327 from SEK 312 at Morgan Stanley
10/27/21 RBC Capital
Alfa Laval price target raised to SEK 400 from SEK 370 at RBC Capital
09/28/21 Morgan Stanley
Alfa Laval price target raised to SEK 312 from SEK 300 at Morgan Stanley
Downgrade
Vestas downgraded to Underweight from Neutral at JPMorgan » 05:06
12/03/21
12/03
05:06
12/03/21
05:06
VWDRY

Vestas

$10.47 /

-0.24 (-2.24%)

JPMorgan analyst Akash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VWDRY Vestas
$10.47 /

-0.24 (-2.24%)

11/09/21 JPMorgan
Vestas price target lowered to DKK 190 from DKK 195 at JPMorgan
11/05/21 Erste Group
Vestas downgraded to Hold on supply chain issues at Erste Group
11/05/21 Erste Group
Vestas downgraded to Hold from Buy at Erste Group
11/04/21 Credit Suisse
Vestas price target raised to DKK 140 from DKK 135 at Credit Suisse
General news
USD-JPY » 05:05
12/03/21
12/03
05:05
12/03/21
05:05
$ECON

Economic Data

/

+

USD-JPY has lifted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Piper 'strongly' encourages buying Minerva shares after Q3 print » 05:00
12/03/21
12/03
05:00
12/03/21
05:00
UTRS

Minerva Surgical

$5.72 /

-0.33 (-5.45%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UTRS Minerva Surgical
$5.72 /

-0.33 (-5.45%)

UTRS Minerva Surgical
$5.72 /

-0.33 (-5.45%)

11/16/21
Fly Intel: Top five analyst initiations
11/16/21 SVB Leerink
SVB Leerink bullish on Minerva Surgical, initiates with an Outperform
11/16/21 SVB Leerink
Minerva Surgical initiated with an Outperform at SVB Leerink
11/16/21 UBS
Minerva Surgical initiated with a Buy at UBS
UTRS Minerva Surgical
$5.72 /

-0.33 (-5.45%)

  • 22
    Oct
UTRS Minerva Surgical
$5.72 /

-0.33 (-5.45%)

Initiation
Alphatec initiated with a Neutral at Goldman Sachs » 04:58
12/03/21
12/03
04:58
12/03/21
04:58
ATEC

Alphatec

$11.04 /

+0.285 (+2.65%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATEC Alphatec
$11.04 /

+0.285 (+2.65%)

ATEC Alphatec
$11.04 /

+0.285 (+2.65%)

10/28/21 Loop Capital
Alphatec initiated with a Buy at Loop Capital
09/28/21 Piper Sandler
Piper Sandler still bullish on Alphatec, views any weakness as good entry point
08/30/21 Lake Street
Alphatec shares 'on sale' amid transitory headwinds, says Lake Street
08/25/21 Needham
Needham starts Alphatec at Buy, sees 'multiple near-term growth opportunities'
ATEC Alphatec
$11.04 /

+0.285 (+2.65%)

ATEC Alphatec
$11.04 /

+0.285 (+2.65%)

Initiation
LivaNova initiated with a Buy at Goldman Sachs » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
LIVN

LivaNova

$82.31 /

+1.67 (+2.07%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIVN LivaNova
$82.31 /

+1.67 (+2.07%)

LIVN LivaNova
$82.31 /

+1.67 (+2.07%)

11/15/21 Piper Sandler
LivaNova financing likely after court ruling, says Piper Sandler
11/03/21 Piper Sandler
LivaNova price target raised to $105 from $100 at Piper Sandler
09/15/21 Piper Sandler
LivaNova to drive 'meaningful shareholder value,' says Piper Sandler
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
LIVN LivaNova
$82.31 /

+1.67 (+2.07%)

  • 04
    Aug
LIVN LivaNova
$82.31 /

+1.67 (+2.07%)

Conference/Events
ITT management to meet virtually with DA Davidson » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
ITT

ITT

$96.44 /

+2.42 (+2.57%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITT ITT
$96.44 /

+2.42 (+2.57%)

ITT ITT
$96.44 /

+2.42 (+2.57%)

11/05/21 Citi
ITT price target raised to $116 from $111 at Citi
06/15/21 Citi
ITT initiated with a Buy at Citi
05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
ITT ITT
$96.44 /

+2.42 (+2.57%)

Conference/Events
Paylocity management to meet virtually with Mizuho » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
PCTY

Paylocity

$257.67 /

+8.33 (+3.34%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCTY Paylocity
$257.67 /

+8.33 (+3.34%)

PCTY Paylocity
$257.67 /

+8.33 (+3.34%)

11/05/21 Cowen
Paylocity price target raised to $330 from $300 at Cowen
11/05/21 Mizuho
Paylocity price target raised to $300 from $280 at Mizuho
10/21/21 Mizuho
Paylocity price target raised to $280 from $220 at Mizuho
10/19/21 JMP Securities
Paylocity price target raised to $310 from $272 at JMP Securities
PCTY Paylocity
$257.67 /

+8.33 (+3.34%)

PCTY Paylocity
$257.67 /

+8.33 (+3.34%)

Conference/Events
Unity Biotechnology management to meet virtually with Mizuho » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
UBX

Unity Biotechnology

$1.89 /

-0.04 (-2.08%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
$1.89 /

-0.04 (-2.08%)

UBX Unity Biotechnology
$1.89 /

-0.04 (-2.08%)

11/09/21 Mizuho
Unity Biotechnology upgraded to Buy from Neutral at Mizuho
06/28/21 Citi
Unity Biotechnology double upgraded to Buy at Citi after 50% pullback
06/28/21 Citi
Unity Biotechnology upgraded to Buy from Sell at Citi
06/07/21 H.C. Wainwright
Unity Biotechnology initiated with a Buy at H.C. Wainwright
UBX Unity Biotechnology
$1.89 /

-0.04 (-2.08%)

Conference/Events
UBS technology analysts to hold an analyst/industry conference call » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
DOCU

DocuSign

$233.83 /

+2.77 (+1.20%)

Technology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

04:47 Today Piper Sandler
DocuSign downgraded to Neutral from Overweight at Piper Sandler
04:45 Today UBS
DocuSign downgraded to Neutral from Buy at UBS
04:43 Today JPMorgan
DocuSign downgraded to Underweight from Neutral at JPMorgan
10/06/21
DocuSign participates in a conference call with Benchmark
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

Conference/Events
Cantor Fitzgerald biopharma analysts to hold analyst/industry conference call » 04:55
12/03/21
12/03
04:55
12/03/21
04:55
JNJ

Johnson & Johnson

$157.08 /

-1.06 (-0.67%)

, PFE

Pfizer

$53.02 /

-1.65 (-3.02%)

, MRNA

Moderna

$301.46 /

-9.24 (-2.97%)

, GSK

GlaxoSmithKline

$41.48 /

+0.12 (+0.29%)

, MRK

Merck

$73.89 /

-0.54 (-0.73%)

, CDTX

Cidara Therapeutics

$1.46 /

-0.025 (-1.69%)

, ARDS

Aridis Pharmaceuticals

$2.13 /

-0.08 (-3.62%)

Large Cap and Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

ARDS Aridis Pharmaceuticals
$2.13 /

-0.08 (-3.62%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
PFE Pfizer
$53.02 /

-1.65 (-3.02%)

11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
MRNA Moderna
$301.46 /

-9.24 (-2.97%)

12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

11/30/21 H.C. Wainwright
Vir Biotechnology price target raised to $200 from $135 at H.C. Wainwright
11/24/21 Berenberg
GlaxoSmithKline price target raised to 1,630 GBp from 1,540 GBp at Berenberg
11/08/21 UBS
GlaxoSmithKline price target raised to 1,500 GBp from 1,460 GBp at UBS
11/05/21 Barclays
GlaxoSmithKline upgraded to Equal Weight from Underweight at Barclays
MRK Merck
$73.89 /

-0.54 (-0.73%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

09/22/21 WBB Securities
Cidara Therapeutics upgraded to Strong Buy from Buy at WBB Securities
03/04/21 Aegis
Cidara Therapeutics initiated with a Buy at Aegis
ARDS Aridis Pharmaceuticals
$2.13 /

-0.08 (-3.62%)

11/11/21 Northland
Aridis Pharmaceuticals price target lowered to $10 from $22 at Northland
07/20/21 H.C. Wainwright
Aridis Pharmaceuticals price target raised to $19 from $11 at H.C. Wainwright
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

ARDS Aridis Pharmaceuticals
$2.13 /

-0.08 (-3.62%)

  • 08
    Oct
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

ARDS Aridis Pharmaceuticals
$2.13 /

-0.08 (-3.62%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

GSK GlaxoSmithKline
$41.48 /

+0.12 (+0.29%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

ARDS Aridis Pharmaceuticals
$2.13 /

-0.08 (-3.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.